Form 4: AtriCure Executive Salvatore Privitera Acquires Shares Through Employee Stock Purchase Plan

AtriCure's Chief Technical Officer, Salvatore Privitera, acquired 707 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a discounted price of $19.35 per share.

Summary

• On June 28, 2024, Salvatore Privitera, Chief Technical Officer of AtriCure, Inc., acquired 707 shares of AtriCure common stock.
• The acquisition was made through the company's 2018 Employee Stock Purchase Plan (ESPP).
• The purchase price was $19.35 per share, based on 85% of the closing price of AtriCure's common stock on June 28, 2024, which was $22.77.
• Following the transaction, Privitera directly owns 103,997 shares of AtriCure common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The transaction reflects an executive's investment in the company, which is generally a good sign, but it's part of a standard employee program.

Positives

• The acquisition of shares by a company executive through the ESPP demonstrates confidence in the company's future.

Industry Context

Insider transactions are routinely monitored and reported to the SEC. Purchases through ESPPs are common and generally viewed positively as they align employee interests with shareholder interests.

Comparison to Industry Standards

• ESPPs are a common benefit offered by many publicly traded companies, including those in the medical device industry like Medtronic and Boston Scientific.
• The discount offered through ESPPs typically ranges from 10% to 15%, aligning with AtriCure's 15% discount in this instance.

Stakeholder Impact

• The transaction could have a slightly positive impact on shareholders as it signals confidence from a company executive.

Key Dates